Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovaza for Antipsychotic-Associated Hypertriglyceridemia
NCT00833976Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2009
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of eicosapentaenoic acid + docosahexaenoic acid in hypertriglyceridemia, hypercholesterolemia, sponsored by Massachusetts General Hospital. Started Jul 2009; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
hypertriglyceridemiahypercholesterolemia
Beyond the preview
Go deeper on NCT00833976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00833976.